1. Market Research
  2. > Pharmaceutical
  3. > Therapy
  4. > Oncology Market Trends
Russia In Vitro Fertilization Market - Opportunity Analysis and Industry Forecast, 2014-2022

Russia In Vitro Fertilization Market - Opportunity Analysis and Industry Forecast, 2014-2022

  • July 2017
  • 77 pages
  • ID: 5056876
  • Format: PDF
  • Allied Market Research


Table of Contents

In vitro fertilization (IVF) is a complex series of procedures used to treat fertility or genetic problems associated with fertility and assist with child conception. During IVF, mature eggs are collected (retrieved) from the ovaries and fertilized by the sperm cell in a laboratory, followed by the implantation of the fertilized egg (embryo) or eggs in the uterus. The Russia IVF market accounted for $398 million in 2015, and is estimated to reach at $641 million by 2022, registering a CAGR of 7.0% from 2016 to 2022.

IVF is a popular treatments that aids couples with infertility problems, single mothers, and the LGBT community to procreate. The Russia IVF market is expected to witness a substantial growth rate in the future, owing to high incidence of infertility cases, emergent trend of delayed pregnancies among women, technological developments in IVF procedures, and increased incidence of gamete donations.

Growth of the market is further augmented by the low-cost clinical settings for IVF treatments in comparison to U.S., UK, and other established markets. Popularity of Russia for medical tourism, owing to advanced IVF facilities and treatment options, supplement the market growth. However, poor reimbursement policies associated with IVF treatment are anticipated to impede the market growth during the forecast period. Furthermore, rise in concern of single parents and same-sex couples in experiencing parenthood through artificial reproductive technology (ART), especially IVF, is expected to present numerous opportunities for market expansion.

The Russia IVF market is segmented based on end user, cycle type, type, drug, and mode of administration. Based on end user, it is divided into fertility clinics, hospitals, surgical centers, and clinical research institutes. The cycle type is classified into fresh IVF cycles (non-donor), thawed IVF cycles (non-donor), and donor egg IVF cycles. Based on type, the market is bifurcated into non-ICSI IVF cycles and ICSI-assisted IVF cycles. On the basis of drug, it is classified into clomiphene citrate, aromatase inhibitors, gonadotropins & gonadotropin-releasing hormone, follicle-stimulating hormone, progesterone, and others. Mode of administration includes oral, injectable, and vaginal modes.


This report provides a detailed quantitative analysis of the current trends in the Russia IVF market from 2014 to 2022 to identify the prevailing opportunities.
Market estimations are based on comprehensive analysis of the key developments in the industry.
In-depth analysis based on drugs and end users assists to understand the market and the strategic business planning.
The developmental strategies adopted by key manufacturers are enlisted to understand the competitive scenario of the market.

Key Market Segments

By End User

Fertility Clinics
Surgical Centers
Clinical Research Institutes

By Cycle Type

Fresh IVF Cycles (Non-donor)
Thawed IVF Cycles (Non-donor)
Donor egg IVF Cycles

By Type

Non-ICSI IVF Cycles
ICSI-assisted IVF Cycles

By Drug

Clomiphene Citrate
Aromatase Inhibitors
Gonadotropins & Gonadotropin-releasing Hormone
Follicle-stimulating Hormone

By Mode of Administration



Ava-Peter Clinic
MD Medical Group
IVF Russia Agilent Technologies

The other players in the value chain include (profiles not included in the report):

Vitrolife AB
EMD Serono, Inc.
Irvine Scientific
Cooper Surgical, Inc.
Cook Medical, Inc.
Thermo Fisher Scientific, Inc.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

RELUGOLIX (TAK-385) - Emerging Insight and Market Forecast – 2030

  • $ 3250
  • October 2020
  • 50 pages

“RELUGOLIX (TAK-385) - Emerging Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product for Endometriosis in 7 Major Markets. A detailed picture ...

  • Japan
  • United States
  • Research And Development
  • Hormone
  • Industry analysis
  • Health Expenditure

Farydak $ 10000 August 2018


Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on